Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Rossi

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Journal of Neuropathology and Experimental Neurology|April 19, 2017
Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?Valeria Barresi, Simona Lionti, Laura Valori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2017
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitorsSabrina Rossi, Luca Toschi, Angelo Castello, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
The American Journal of Surgical Pathology|May 10, 2011
Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 casesMark Jentoft, Caterina Giannini, Sabrina Rossi, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 25, 2020
Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapySimona Monterisi, Angelo Castello, Luca Toschi, et al.
Drugs in Context|November 24, 2017
Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapiesSabrina Rossi, Alessandra Cassano, Antonia Strippoli, et al.
Medicine|April 20, 2017
Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathyMichela Quirino, Sabrina Rossi, Giovanni Schinzari, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2004
Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibodySabrina Rossi, Enrico Orvieto, Alberto Furlanetto, et al.
Mutation Research|April 12, 2002
Biomonitoring of primary aluminium industry workers: detection of micronuclei and repairable DNA lesions by alkaline SCGERiccardo Crebelli, Plinio Carta, Cristina Andreoli, et al.
Current Treatment Options in Oncology|October 22, 2016
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?Ettore D'Argento, Sabrina Rossi, Giovanni Schinzari, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Journal of Neuropathology and Experimental Neurology|April 19, 2017
Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?Valeria Barresi, Simona Lionti, Laura Valori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2017
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitorsSabrina Rossi, Luca Toschi, Angelo Castello, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
The American Journal of Surgical Pathology|May 10, 2011
Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 casesMark Jentoft, Caterina Giannini, Sabrina Rossi, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 25, 2020
Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapySimona Monterisi, Angelo Castello, Luca Toschi, et al.
Drugs in Context|November 24, 2017
Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapiesSabrina Rossi, Alessandra Cassano, Antonia Strippoli, et al.
Medicine|April 20, 2017
Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathyMichela Quirino, Sabrina Rossi, Giovanni Schinzari, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2004
Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibodySabrina Rossi, Enrico Orvieto, Alberto Furlanetto, et al.
Mutation Research|April 12, 2002
Biomonitoring of primary aluminium industry workers: detection of micronuclei and repairable DNA lesions by alkaline SCGERiccardo Crebelli, Plinio Carta, Cristina Andreoli, et al.
Current Treatment Options in Oncology|October 22, 2016
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?Ettore D'Argento, Sabrina Rossi, Giovanni Schinzari, et al.
Pageof 19